Alembic Pharma receives 11 USFDA product approvals (final & tentative) during quarter ended 30 June Ruchika Sharma5 July 2024 4:16 PM ISTVadodara: Alembic Pharma has announced the receipt of 11 product approvals both final and tentative from the US Food & Drug...
USFDA approves Alembic Pharma Icatibant Injection for acute attacks of hereditary angioedema Ruchika Sharma17 Jun 2024 3:29 PM ISTIcatibant injection is indicated for the treatment of acute attacks of hereditary angioedema in adults 18 years of age and older.
Aurobindo Pharma arm secures USFDA okay for Icatibant Injection Ruchika Sharma16 Aug 2023 2:30 PM ISTIcatibant Injection is indicated for treatment of acute attacks of hereditary angioedema in adults 18 years of age and older.
CDSCO Panel Tells MSN Lab to Produce Raw Data on Icatibant Injection Dr. Divya Colin24 Oct 2022 1:15 PM ISTNew Delhi: In response to drug maker MSN Laboratories' justification for bioavailability (BE) study waiver for Icatibant Injection 30mg/3ml (10mg/ml)...
Glenmark gets USFDA nod for Single-Dose Prefilled Icatibant Injection Ruchika Sharma24 May 2021 1:21 PM ISTMumbai: Drugmaker, Glenmark Pharmaceuticals Limited, today announced that the company has received final approval by the United States Food &...
